137 related articles for article (PubMed ID: 8998844)
1. Relationship between the 13C-NMR chemical shift and the carcinogenic activity of benz[a]anthracenes.
Sakamoto Y; Aoki T; Ohshima S
Chem Pharm Bull (Tokyo); 1996 Feb; 44(2):424-8. PubMed ID: 8998844
[TBL] [Abstract][Full Text] [Related]
2. Effects of methyl substitutions on benz[a]anthracene derivatives-induced immunosuppression.
Saas P; Bohuon C; Pallardy M
J Toxicol Environ Health; 1996 Nov; 49(4):371-87. PubMed ID: 8931739
[TBL] [Abstract][Full Text] [Related]
3. Benz[a]anthracene diols: predicted carcinogenicity and structure-estrogen receptor binding affinity relationships.
Anstead GM; Kym PR
Steroids; 1995 May; 60(5):383-94. PubMed ID: 7570711
[TBL] [Abstract][Full Text] [Related]
4. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
Utesch D; Glatt H; Oesch F
Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
[TBL] [Abstract][Full Text] [Related]
5. Mouse skin tumor-initiating activity of 5-, 7-, and 12-methyl- and fluorine-substituted benz[a]anthracenes.
Wood AW; Levin W; Chang RL; Conney AH; Slaga TJ; O'Malley RF; Newman MS; Buhler DR; Jerina DM
J Natl Cancer Inst; 1982 Sep; 69(3):725-8. PubMed ID: 6810009
[TBL] [Abstract][Full Text] [Related]
6. Mouse skin tumor initiating activity of fluorinated derivatives of 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene.
Nair RV; Walker SE; Sharma PK; Witiak DT; DiGiovanni J
Chem Res Toxicol; 1992; 5(2):153-6. PubMed ID: 1643244
[No Abstract] [Full Text] [Related]
7. Relations between the averaged 13C nuclear magnetic resonance chemical shift and the carcinogenic activity of polycyclic aromatic hydrocarbons.
Sakamoto Y; Ohshima S; Ohmoto T
Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):1981-5. PubMed ID: 1423755
[TBL] [Abstract][Full Text] [Related]
8. Exceptional carcinogenic activity of benz[a]anthracene 3,4-dihydrodiol in the newborn mouse and the bay region theory.
Wislocki PG; Kapitulnik J; Levin W; Lehr R; Schaefer-Ridder M; Karle JM; Jerina DM; Conney AH
Cancer Res; 1978 Mar; 38(3):693-6. PubMed ID: 626973
[TBL] [Abstract][Full Text] [Related]
9. Carcinogenicity of derivatives of 7,12-dimethylbenz(a)anthracene.
Flesher JW; Sydnor KL
Cancer Res; 1971 Dec; 31(12):1951-4. PubMed ID: 5120292
[No Abstract] [Full Text] [Related]
10. K-region oxides and imines derived from alkylated benz[a]anthracene congeners: synthesis, stability in aqueous media and mutagenicity.
Glatt H; Abu-Shqara E; Martiné U; Baidossi W; Harvey RG; Blum J
Mutagenesis; 1994 Mar; 9(2):83-92. PubMed ID: 8201951
[TBL] [Abstract][Full Text] [Related]
11. Structure-carcinogenic activity relationships in the Benz [a] anthracene series.
Newman MS; Hung WM
J Med Chem; 1977 Jan; 20(1):179-81. PubMed ID: 401890
[TBL] [Abstract][Full Text] [Related]
12. Relationship between resonance energy and carcinogenic activity of benz[c]acridines.
Motohashi N; Kurihara T; Sakagami H; Molnar J
Anticancer Res; 1992; 12(6B):2105-8. PubMed ID: 1295454
[TBL] [Abstract][Full Text] [Related]
13. NMR chemical shifts in carcinogenic polynuclear hydrocarbons.
Bartle KD; Jones DW; Matthews RS
J Med Chem; 1969 Nov; 12(6):1062-5. PubMed ID: 5351447
[No Abstract] [Full Text] [Related]
14. The genotoxicity of benzanthracenes: a quantitative structure-activity study.
Lewis DF; Parke DV
Mutat Res; 1995 May; 328(2):207-14. PubMed ID: 7739604
[TBL] [Abstract][Full Text] [Related]
15. Quantum chemical studies of methylbenz[a]anthracenes: metabolism and correlations with carcinogenicity.
Loew G; Poulsen M; Ferrell J; Chaet D
Chem Biol Interact; 1980 Sep; 31(3):319-40. PubMed ID: 7408039
[TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics of some carcinogenic hydrocarbons.
Cavalieri E; Calvin M
Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1251-3. PubMed ID: 5288372
[TBL] [Abstract][Full Text] [Related]
17. Molecular structures of the chemical carcinogens 7-chloromethylbenz(a)anthracene and 7-chloromethyl-12-methylbenz(a)anthracene.
Glusker JP; Zacharias DE; Carrell HL
Cancer Res; 1976 Jul; 36(7 PT 1):2428-35. PubMed ID: 1277150
[TBL] [Abstract][Full Text] [Related]
18. Comparative carcinogenicity of picene and dibenz[a,h]anthracene in the rat.
Flesher JW; Horn J; Lehner AF
Biochem Biophys Res Commun; 2002 Jan; 290(1):275-9. PubMed ID: 11779165
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, absolute configuration, and bacterial mutagenicity of the 8 stereoisomeric vicinal diol epoxides at the terminal benzo ring of carcinogenic dibenz[a,h]anthracene.
Frank H; Funk M; Oesch F; Platt KL
Chem Res Toxicol; 2011 Dec; 24(12):2258-68. PubMed ID: 22087540
[TBL] [Abstract][Full Text] [Related]
20. Intercalation of the (-)-(1R,2S,3R, 4S)-N6-[1-benz[a]anthracenyl]-2'-deoxyadenosyl adduct in an oligodeoxynucleotide containing the human N-ras codon 61 sequence.
Li Z; Mao H; Kim HY; Tamura PJ; Harris CM; Harris TM; Stone MP
Biochemistry; 1999 Mar; 38(10):2969-81. PubMed ID: 10074349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
